125 related articles for article (PubMed ID: 31163215)
1. Inhibition of human cytochrome P450 2A6 by 7-hydroxycoumarin analogues: Analysis of the structure-activity relationship and isoform selectivity.
Qi X; Dou T; Wang Z; Wu J; Yang L; Zeng S; Deng M; Lü M; Liang S
Eur J Pharm Sci; 2019 Aug; 136():104944. PubMed ID: 31163215
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of cytochrome P450 enzymes CYP1A2, CYP2A6, CYP2E1 and CYP3A4 by extracts and alkaloids of Gelsemium elegans roots.
Wang Y; Wu S; Chen Z; Zhang H; Zhao W
J Ethnopharmacol; 2015 May; 166():66-73. PubMed ID: 25764964
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of coumarin derivatives as selective CYP2A6 inhibitors.
Yamaguchi Y; Nishizono N; Kobayashi D; Yoshimura T; Wada K; Kobayashi K; Oda K
Bioorg Med Chem Lett; 2023 Apr; 86():129206. PubMed ID: 36889653
[TBL] [Abstract][Full Text] [Related]
4. In vitro inhibition of cytochrome P450 enzymes in human liver microsomes by a potent CYP2A6 inhibitor, trans-2-phenylcyclopropylamine (tranylcypromine), and its nonamine analog, cyclopropylbenzene.
Taavitsainen P; Juvonen R; Pelkonen O
Drug Metab Dispos; 2001 Mar; 29(3):217-22. PubMed ID: 11181487
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human cytochrome P450 enzymes by the natural hepatotoxin safrole.
Ueng YF; Hsieh CH; Don MJ
Food Chem Toxicol; 2005 May; 43(5):707-12. PubMed ID: 15778010
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects and oxidation of 6-methylcoumarin, 7-methylcoumarin and 7-formylcoumarin via human CYP2A6 and its mouse and pig orthologous enzymes.
Juvonen RO; Kuusisto M; Fohrgrup C; Pitkänen MH; Nevalainen TJ; Auriola S; Raunio H; Pasanen M; Pentikäinen OT
Xenobiotica; 2016; 46(1):14-24. PubMed ID: 26068522
[TBL] [Abstract][Full Text] [Related]
7. In vitro inhibitory mechanisms and molecular docking of 1'-S-1'-acetoxychavicol acetate on human cytochrome P450 enzymes.
Haque AKMM; Leong KH; Lo YL; Awang K; Nagoor NH
Phytomedicine; 2017 Jul; 31():1-9. PubMed ID: 28606510
[TBL] [Abstract][Full Text] [Related]
8. Single-dose methoxsalen effects on human cytochrome P-450 2A6 activity.
Kharasch ED; Hankins DC; Taraday JK
Drug Metab Dispos; 2000 Jan; 28(1):28-33. PubMed ID: 10611136
[TBL] [Abstract][Full Text] [Related]
9. Synthetic models related to methoxalen and menthofuran-cytochrome P450 (CYP) 2A6 interactions. benzofuran and coumarin derivatives as potent and selective inhibitors of CYP2A6.
Yamaguchi Y; Akimoto I; Motegi K; Yoshimura T; Wada K; Nishizono N; Oda K
Chem Pharm Bull (Tokyo); 2013; 61(10):997-1001. PubMed ID: 23902929
[TBL] [Abstract][Full Text] [Related]
10. Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes.
Wen X; Wang JS; Neuvonen PJ; Backman JT
Eur J Clin Pharmacol; 2002 Jan; 57(11):799-804. PubMed ID: 11868802
[TBL] [Abstract][Full Text] [Related]
11. Single-dose disulfiram does not inhibit CYP2A6 activity.
Kharasch ED; Hankins DC; Baxter PJ; Thummel KE
Clin Pharmacol Ther; 1998 Jul; 64(1):39-45. PubMed ID: 9695717
[TBL] [Abstract][Full Text] [Related]
12. Rational design of novel CYP2A6 inhibitors.
Tani N; Juvonen RO; Raunio H; Fashe M; Leppänen J; Zhao B; Tyndale RF; Rahnasto-Rilla M
Bioorg Med Chem; 2014 Dec; 22(23):6655-6664. PubMed ID: 25458499
[TBL] [Abstract][Full Text] [Related]
13. In vitro evaluation of valproic acid as an inhibitor of human cytochrome P450 isoforms: preferential inhibition of cytochrome P450 2C9 (CYP2C9).
Wen X; Wang JS; Kivistö KT; Neuvonen PJ; Backman JT
Br J Clin Pharmacol; 2001 Nov; 52(5):547-53. PubMed ID: 11736863
[TBL] [Abstract][Full Text] [Related]
14. Inhibition selectivity of grapefruit juice components on human cytochromes P450.
Tassaneeyakul W; Guo LQ; Fukuda K; Ohta T; Yamazoe Y
Arch Biochem Biophys; 2000 Jun; 378(2):356-63. PubMed ID: 10860553
[TBL] [Abstract][Full Text] [Related]
15. Isoform selective inhibition and inactivation of human cytochrome P450s by methylenedioxyphenyl compounds.
Nakajima M; Suzuki M; Yamaji R; Takashina H; Shimada N; Yamazaki H; Yokoi T
Xenobiotica; 1999 Dec; 29(12):1191-202. PubMed ID: 10647906
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of coumarin 7-hydroxylase activity in human liver microsomes.
Draper AJ; Madan A; Parkinson A
Arch Biochem Biophys; 1997 May; 341(1):47-61. PubMed ID: 9143352
[TBL] [Abstract][Full Text] [Related]
17. Inhibition effects of Vernonia cinerea active compounds against cytochrome P450 2A6 and human monoamine oxidases, possible targets for reduction of tobacco dependence.
Prasopthum A; Pouyfung P; Sarapusit S; Srisook E; Rongnoparut P
Drug Metab Pharmacokinet; 2015 Apr; 30(2):174-81. PubMed ID: 25857233
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of 7-benzyloxy-4-trifluoromethyl-coumarin by human hepatic cytochrome P450 isoforms.
Renwick AB; Surry D; Price RJ; Lake BG; Evans DC
Xenobiotica; 2000 Oct; 30(10):955-69. PubMed ID: 11315104
[TBL] [Abstract][Full Text] [Related]
19. Thiomers: Inhibition of cytochrome P450 activity.
Iqbal J; Sakloetsakun D; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2011 Aug; 78(3):361-5. PubMed ID: 21362475
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug-drug interactions.
Katoh M; Nakajima M; Shimada N; Yamazaki H; Yokoi T
Eur J Clin Pharmacol; 2000; 55(11-12):843-52. PubMed ID: 10805063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
